{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:07:53Z","timestamp":1777576073307,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Polymer\u2010free sirolimus\u2010 and probucol\u2010eluting stents (<jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>eal <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual drug\u2010eluting stents [<jats:styled-content style=\"fixed-case\">DES<\/jats:styled-content>]) is as effective as first\u2010generation <jats:styled-content style=\"fixed-case\">DES<\/jats:styled-content> in treating coronary artery stenosis. It is unknown whether sirolimus\u2010eluting stents containing biodegradable polymer (<jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>xcel) would be superior to real <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">DES<\/jats:styled-content>. This study aimed to investigate the difference in target vessel revascularization (<jats:styled-content style=\"fixed-case\">TVR<\/jats:styled-content>) at 12\u00a0months in patients with coronary artery disease treated by the implantation of <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES or Excel stents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Three hundred and forty\u2010six patients with de novo coronary artery disease were recruited from six centers in China and randomly assigned to either the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES or the Excel group. The primary endpoint was the occurrence of <jats:styled-content style=\"fixed-case\">TVR<\/jats:styled-content> at 12\u00a0months. The secondary endpoint was angiographic in\u2010stent restenosis and late lumen loss at 13\u00a0months. Stent thrombosis (<jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content>) served as the safety endpoint. Dual anti\u2010platelet therapy (<jats:styled-content style=\"fixed-case\">DAPT<\/jats:styled-content>) was prescribed for 6\u00a0months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinical follow\u2010up for 12\u00a0months and repeat angiography at 13\u00a0months were available in 100% and &gt;90% of patients, respectively. The <jats:styled-content style=\"fixed-case\">ISR<\/jats:styled-content> and in\u2010stent late loss were significantly different between the <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>xcel (3.1%, 0.09\u00a0\u00b1\u00a00.11\u00a0mm) and the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES (19.5%, 0.36\u00a0\u00b1\u00a00.32\u00a0mm, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001, respectively) groups. The <jats:styled-content style=\"fixed-case\">TVR<\/jats:styled-content> (3.5%) in the <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>xcel group was significantly less than in the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES group (13.9%, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.001). The <jats:styled-content style=\"fixed-case\">ST<\/jats:styled-content> rate beyond 12\u00a0months in the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES group was 0%, and this was 1.2% in the <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>xcel group (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.499).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>xcel stent was statistically superior to the <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ual <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ES in terms of restenosis, late loss, and <jats:styled-content style=\"fixed-case\">TVR<\/jats:styled-content> for long lesions.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1755-5922.2012.00319.x","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T11:54:35Z","timestamp":1337946875000},"page":"193-200","source":"Crossref","is-referenced-by-count":9,"title":["Real Polymer\u2010Free Sirolimus\u2010 and Probucol\u2010Eluting Versus Biodegradable Polymer Sirolimus\u2010Eluting Stents for Obstructive Coronary Artery Disease: <scp>DKPLUS<\/scp>\u2010Wave 1, a Multicenter, Randomized, Prospective Trial"],"prefix":"10.1111","volume":"31","author":[{"given":"Shao\u2010Liang","family":"Chen","sequence":"first","affiliation":[{"name":"Nanjing First Hospital Nanjing Medical University Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[{"name":"Nanjing First Hospital Nanjing Medical University Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun\u2010Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nanjing First Hospital Nanjing Medical University Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian\u2010Jun","family":"Zou","sequence":"additional","affiliation":[{"name":"Nanjing Heart Center Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue\u2010Song","family":"Qian","sequence":"additional","affiliation":[{"name":"ZhangjiaGang People's Hospital Zhangjiagang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Oriental General Hospital Huainan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[{"name":"Yixin People's Hospital Yixin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Ge","sequence":"additional","affiliation":[{"name":"Nanjing Heart Center Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou\u2010Jie","family":"Shan","sequence":"additional","affiliation":[{"name":"Nanjing First Hospital Nanjing Medical University Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2010Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Nanjing Heart Center Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[{"name":"ZhangjiaGang People's Hospital Zhangjiagang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Kan","sequence":"additional","affiliation":[{"name":"Oriental General Hospital Huainan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[{"name":"Yixin People's Hospital Yixin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u2010Ling","family":"Han","sequence":"additional","affiliation":[{"name":"Shenyang Northen Hospital Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012843"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035071"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc4201.098056"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116202.41966.D4"},{"key":"e_1_2_8_6_1","article-title":"Angioscopic study from a large patient population comparing sirolimus\u2010eluting stent with biodegradable versus dural polymer","author":"Chen SL","year":"2011","journal-title":"Catheterization Cardiovasc Interv"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp480"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000157579.52566.ee"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp044"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026732"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1903"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.10.005"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2008.12.013"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.18.1872"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067731"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.78.2.486"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.144220"},{"key":"e_1_2_8_18_1","first-page":"567","article-title":"Polymer coatings and delayed arterial healing following drug\u2010eluting stent implantation","volume":"57","author":"Byrne RA","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV6I1A19"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.31988"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi405"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.1.30"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.027"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23113"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.023"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.07.010"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000118474.71662.E3"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5922.2012.00319.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-5922.2012.00319.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:49:07Z","timestamp":1696326547000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-5922.2012.00319.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,18]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1111\/j.1755-5922.2012.00319.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-5922.2012.00319.x","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,18]]}}}